Discount drugs dilemma: The Tipline for 8 May 2019
Congress is once again grappling with how to combat soaring drug prices for US citizens who struggle to afford healthcare while folks overseas pay a fraction of the US price tag. Senators from both sides of the political aisle yesterday called for less talk and more action to get drug prices under control, even if that means implementing price regulations.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10